Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
Critical Insights From Sangamo Therapeutics Analyst Ratings: What You Need To Know
来自Sangamo Therapeutics分析师评级的关键见解：你需要知道的
In the preceding three months, 4 analysts have released ratings for Sangamo Therapeutics (NASDAQ:SGMO), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有4位分析师公布了Sangamo Therapeutics（纳斯达克股票代码：SGMO）的评级，提出了从看涨到看跌的各种观点。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
下表概述了他们最近的评级，简要介绍了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $3.75, a high estimate of $5.00, and a low estimate of $2.00. Marking an increase of 25.0%, the current average surpasses the previous average price target of $3.00.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为3.75美元，最高估计为5.00美元，低估值为2.00美元。当前的平均价格上涨了25.0％，超过了之前的平均目标股价3.00美元。
Analyzing Analyst Ratings: A Detailed Breakdown
分析分析师评级：详细明细
In examining recent analyst actions, we gain...
在研究分析师最...
登录免费看全文
登录/注册